Device manufacturer, as written on reports
St Jude Medical Crmd: medical device reports filed with FDA
54,941 reports name it as the manufacturer of the device involved, 1998–2015.
- 54,941
- reports naming it as manufacturer
- 0.2% of all MAUDE reports
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 51%
- classified as malfunction
- 62.3% across all reports
- 3.8%
- classified as death, as reported
- 0.9% across all reports
54,941 medical device reports received by FDA give St Jude Medical Crmd as the manufacturer of the device involved, 0.2% of the MAUDE database, from June 1998 to September 2015. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (51%), injury (45.1%) and death (3.8%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Riata Active Fixation | Permanent defibrillator electrodes | 3,156 | 96 | 1.8% |
| Tendril Sts | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 3,032 | 4,320 | 3.1% |
| Tendril St | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 2,998 | 547 | 5.2% |
| Durata Sts Optim Active Fixation Df-4 Connector | Permanent defibrillator electrodes | 2,673 | 1,784 | 3.9% |
| Tendril Sdx | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 2,468 | 3 | 2.3% |
| Quadra Assura Crt-D Df-4 Connector | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 1,830 | 0 | 1.4% |
| Durata Sts Optim Active Fixation | Implantable cardioverter defibrillator (non-crt) | 1,567 | 301 | 5.6% |
| Quartet | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 1,283 | 848 | 5.2% |
| Riata St Active Fixation | Permanent defibrillator electrodes | 1,206 | 76 | 2.2% |
| Riata Passive Fixation | Permanent defibrillator electrodes | 968 | 32 | 1.2% |
| Isoflex Optim Lead | Permanent defibrillator electrodes | 725 | 437 | 2% |
| Quickflex Micro Lv Lead | Drug eluting permanent left ventricular (lv) pacemaker electrode | 722 | 116 | 5.9% |
| Unify Crt-D | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 679 | 10 | 3.4% |
| Isoflex S | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 646 | 0 | 1.7% |
| Optisense | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 639 | 22 | 7.7% |
| Confirm | Recorder, event, implantable cardiac, (without arrhythmia detection) | 584 | 34 | 0.1% |
| Durata Sts Optim Active Fixation Df4 Connector | Permanent defibrillator electrodes | 526 | 0 | 5.1% |
| Unify Assura Crt-D | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 510 | 0 | 1.7% |
| Tendril Dx | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 493 | 69 | 2% |
| Promote Rf Crt-D | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 469 | 0 | 7.9% |
| Unify Crt-D Df-4 Connector | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 386 | 0 | 6.2% |
| Riata Active-Fixation Lead | Implantable cardioverter defibrillator (non-crt) | 361 | 0 | 2% |
| Spl Lead System | Permanent pacemaker electrode | 262 | 0 | 2.5% |
| Riata Active Fixation Lead | Implantable cardioverter defibrillator (non-crt) | 180 | 0 | 0.9% |
| Transvenous Defibrillation Lead System | Implantable cardioverter defibrillator (non-crt) | 144 | 0 | 4.9% |
| Quadra Assura Crt-D | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 129 | 0 | 2% |
| Unify Quadra Crt-D Df-4 Connector | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 120 | 0 | 5.5% |
| Optisure Active Fixation Df-4 Connector | Permanent defibrillator electrodes | 82 | 623 | 4.3% |
| Atlas Plus Vr | Implantable cardioverter defibrillator (non-crt) | 79 | 0 | 3.6% |
| Fortify Assura Vr Df-4 Connector | Implantable cardioverter defibrillator (non-crt) | 76 | 0 | 0.4% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| LWS | Implantable cardioverter defibrillator (non-crt) | 14,251 | 25.9% |
| NVY | Permanent defibrillator electrodes | 9,386 | 17.1% |
| NVN | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 8,561 | 15.6% |
| NIK | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 8,471 | 15.4% |
| DXY | Implantable pacemaker pulse-generator | 4,602 | 8.4% |
| DTB | Permanent pacemaker electrode | 3,844 | 7% |
| LWP | Implantable pulse generator, pacemaker (non-crt) | 2,764 | 5% |
| OJX | Drug eluting permanent left ventricular (lv) pacemaker electrode | 2,042 | 3.7% |
| MXC | Recorder, event, implantable cardiac, (without arrhythmia detection) | 584 | 1.1% |
| NKE | Pulse generator, pacemaker, implantable, with cardiac resynchronization (crt-p) | 120 | 0.2% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about St Jude Medical Crmd reports
How many FDA device reports name St Jude Medical Crmd as manufacturer?
54,941 reports through August 2026, 0 of them in the latest 12 months.
Which of its brands appear most often?
Riata Active Fixation (3,156), Tendril Sts (3,032), Tendril St (2,998), Durata Sts Optim Active Fixation Df-4 Connector (2,673) and Tendril Sdx (2,468).
Which device types does it report on?
implantable cardioverter defibrillator (non-crt) (25.9%), permanent defibrillator electrodes (17.1%), drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes (15.6%) and defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) (15.4%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.